Situated in the affluent suburbs of the Detroit metropolitan area, Beaumont Hospital has rapidly expanded over the last couple decades. Beaumont now boasts a 1,061-bed referral hospital in Royal Oak as well as a 346-bed community hospital in Troy, Michigan. Construction of an entirely new 656,000 square-foot hospital building with 432 inpatient beds was completed in 2005 on the Royal Oak campus. Beaumont-Royal Oak was #1 in the nation for all hospitals in admissions, #2 in total surgeries, and #2 in outpatient surgeries for the year 2004. Over 350 residents and fellows currently train at Beaumont in 35 accredited residency and fellowshop programs and 10 additional non-accredited fellowship programs.
Our Radiation Oncology Department is among the finest in the world, and has the highest patient and treatment volumes in the State of Michigan, treating more that 3,500 patients per year after approximately 4,100 consults per year. The Elekta Synergy® linear accelerator with an on-board cone-beam CT scanner and kV imager for image-guided radiotherapy (IGRT) was invented, designed, and developed in our department. We have recently installed and commissioned the first Elekta Axesse® linear accelerator in the world. This machine is specially designed for CT-based image-guided extracranial radiosurgery with a fully integrated 6D robotic couch. Volumetric image-guided radiotherapy is routinely used to treat patients in the clinic for multiple disease sites.There are a total of four linear accelerators at the primary institution in Royal Oak, as well as three linear accelerators at our secondary institution in Troy, Michigan. In addition, we perform approximately 300 Gamma Knife® intracranial radiosurgery procedures per year and treat approximately 200 patients per year with interstitial or intracavitary brachytherapy implants (approximately 1,000 procedures.) We Treat approximately 40 patients with image-guided extracranial radiosurgery per year as well.
Currently, our department has five active NIH or Congressionally-directed medical research program grants. We have pioneered techniques such as high-dose-rate brachytherapy, adaptive RT, partial breast irradiation (via brachytherapy and 3D conformal external beam RT), integration of CT-PET imaging into the treatment planning process, 4D adaptive image-guided extracranial radiosurgery, and intensity-modulated RT for Prostate, breast. lung, pancreatic, and other malignancies. We have an active Radiobiology Research Group with expertise in clinical, translational and basic radiobiology research. Our radiobiology group is represented on the ASTRO Radiation and Cancer Biology Committee and provides expert teaching in radiobiology and a multitude of research opportunities for residents. Three of our faculty physicians are primary investigators for national Radiation Therapy Oncology Group (RTOG) trials. Our department has been in the top 5 in the world in scientific presentations at ASTRO for at least eight consecutive years. For each of the last 4 years, at least seven of our eight residents presented an abstract at ASTRO as first author, including all eight residents presenting as first author in 2005 and 2007.
Brachytherapy equipment includes one Nucletron low dose rate interstitial remote afterloader and two Nucletron high dose rate remote afterloaders. Sealed isotopic sources include cesium 137, iridium 192, iodine 125, and strontium 90.
Within our hyperthermia suite, external hyperthermia treatments are given using ultrasound and/or radio-frequency units. Interstitial hyperthermia is delivered via a radio-frequency generator and/or two microwave multichannel generators.
The new Research Institute building was completed in 2001, adding significant research laboratory space. An additional 3,000 square feet of laboratory space is dedicated to research in Clinical Physics. Research activities focus on the optimization of advanced treatment techniques. The program includes development of intensity modulated radiation therapy (IMRT), volumetric modulated radiation therapy (VMAT), image-guided radiation therapy, the study of any limits of treatment variation with multi-modality imaging techniques, and the optimization of individual treatment using information obtained from continuous monitoring of patient treatment with on-line imaging or adaptive radiotherapy. The radiobiology research area includes a double "wet" lab (2000 sq ft) , radioisotope lab (400 sq ft), microscopy lab (340 sq ft), physiology lab (400 sq ft), systems development lab (300 sq ft), research offices (800 sq feet), and shared lab spaces including a cold room. warm chamber room housing irradiation facilities, large common lab and a dark room.
Copyright © 2013 Beaumont Health System. All Rights Reserved.